Jóźwik-Plebanek, K.; Saracyn, M.; Kołodziej, M.; Mądra, W.; Durma, A.D.; Dziuk, M.; Balcerska, Z.; Janiak, K.; Gniadek-Olejniczak, K.; Kamiński, G.
Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors. Cancers 2025, 17, 3219.
https://doi.org/10.3390/cancers17193219
AMA Style
Jóźwik-Plebanek K, Saracyn M, Kołodziej M, Mądra W, Durma AD, Dziuk M, Balcerska Z, Janiak K, Gniadek-Olejniczak K, Kamiński G.
Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors. Cancers. 2025; 17(19):3219.
https://doi.org/10.3390/cancers17193219
Chicago/Turabian Style
Jóźwik-Plebanek, Katarzyna, Marek Saracyn, Maciej Kołodziej, Weronika Mądra, Adam Daniel Durma, Mirosław Dziuk, Zuzanna Balcerska, Katarzyna Janiak, Katarzyna Gniadek-Olejniczak, and Grzegorz Kamiński.
2025. "Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors" Cancers 17, no. 19: 3219.
https://doi.org/10.3390/cancers17193219
APA Style
Jóźwik-Plebanek, K., Saracyn, M., Kołodziej, M., Mądra, W., Durma, A. D., Dziuk, M., Balcerska, Z., Janiak, K., Gniadek-Olejniczak, K., & Kamiński, G.
(2025). Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors. Cancers, 17(19), 3219.
https://doi.org/10.3390/cancers17193219
